EPISODE · May 22, 2025 · 34 MIN
Updesh Dosanjh on Reimagining Drug Safety: Why AI Is No Longer Optional
from AI Explained: Healthcare and Life Sciences · host Applonia Cornolius and David Samwel
In this episode of the AI Trailblazers Podcast, we’re joined by Updesh Dosanjh, Global Lead for Pharmacovigilance Technology Solutions at IQVIA, to explore how artificial intelligence is transforming drug safety at a global scale.Updesh shares why traditional pharmacovigilance (PV) methods simply can’t keep up with today’s data volume—and how generative AI, automation, and platform thinking are helping PV teams shift from reactive to proactive safety management.🔍 What you’ll learn in this episode:✅ Why AI is no longer optional in pharmacovigilance✅ How GenAI is streamlining signal detection and case processing✅ Why scaling PV isn’t about hiring more—it’s about thinking differently✅ The biggest mistake teams make when starting their AI journey✅ Why platforms (not point solutions) are the future of safety innovationWhether you're in drug safety, regulatory affairs, or digital transformation, this conversation is packed with real-world insights and bold thinking from one of the industry's leaders.
What this episode covers
In this episode of the AI Trailblazers Podcast, we’re joined by Updesh Dosanjh, Global Lead for Pharmacovigilance Technology Solutions at IQVIA, to explore how artificial intelligence is transforming drug safety at a global scale.Updesh shares why traditional pharmacovigilance (PV) methods simply can’t keep up with today’s data volume—and how generative AI, automation, and platform thinking are helping PV teams shift from reactive to proactive safety management.🔍 What you’ll learn in this episode:✅ Why AI is no longer optional in pharmacovigilance✅ How GenAI is streamlining signal detection and case processing✅ Why scaling PV isn’t about hiring more—it’s about thinking differently✅ The biggest mistake teams make when starting their AI journey✅ Why platforms (not point solutions) are the future of safety innovationWhether you're in drug safety, regulatory affairs, or digital transformation, this conversation is packed with real-world insights and bold thinking from one of the industry's leaders.
NOW PLAYING
Updesh Dosanjh on Reimagining Drug Safety: Why AI Is No Longer Optional
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m